Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catalex Bio is a leading Indian biotechnology company that specializes in the manufacture, supply, and export of industrial and specialty enzymes. Headquartered in Ahmedabad, Gujarat, the company serves a diverse array of industries, including food and beverages, pharmaceuticals, nutraceuticals, animal nutrition, and textiles. Their comprehensive product portfolio includes essential enzymes such as protease, amylase, lipase, and cellulase, alongside plant-derived options like bromelain and papain. Catalex Bio operates out of GMP-, ISO-, and FSSAI-certified facilities, ensuring that their products meet rigorous international quality and safety standards. In addition to standard enzyme offerings, the company provides customized multi-enzyme blends and probiotic solutions tailored to specific industrial applications. By focusing on application-driven solutions, Catalex Bio helps global B2B partners improve process efficiency, product consistency, and overall sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Catalex Bio.